Galapagos Nears First Drug Approval with Phase III Success in Rheumatoid Arthritis - Labiotech.eu

Galapagos Nears First Drug Approval with Phase III Success in Rheumatoid Arthritis  Labiotech.eu

Galapagos has released positive data from two phase III trials testing its flagship drug candidate, filgotinib, that will let the company and its partner Gilead apply ...